Aspirin is a widely used nonsteroidal anti-inflammatory drug (NSAID) that has been shown to have beneficial effects on cardiovascular health, including reducing the risk of heart attack and stroke. One of the key mechanisms by which aspirin achieves these benefits is through its ability to inhibit platelet aggregation, which is the process by which platelets clump together to form blood clots [1].
Exercise, on the other hand, has been shown to have complex effects on platelet function. Research has indicated that regular exercise can lead to increased platelet activation and aggregation, particularly in individuals who are not used to regular physical activity [2]. However, in habitual exercisers, exercise has been shown to have anti-thrombotic effects, meaning it can help to prevent blood clot formation [3].
When it comes to the interaction between aspirin and exercise-induced changes in platelet function, research suggests that aspirin may have a protective effect. Studies have shown that aspirin can help to counteract the pro-thrombotic effects of exercise in non-habitual exercisers, reducing the risk of platelet aggregation and blood clot formation [4]. However, the optimal dose and timing of aspirin administration in relation to exercise is not well established [5].
According to DrugPatentWatch.com, the patent for aspirin has expired, making it available as a generic medication [6]. This has contributed to aspirin becoming one of the most widely used medications in the world.
In terms of the molecular mechanisms underlying the interaction between aspirin and exercise-induced changes in platelet function, research suggests that aspirin inhibits the enzyme cyclooxygenase (COX), which is involved in the production of thromboxane A2, a potent platelet activator [7]. Exercise, particularly in non-habitual exercisers, can lead to increased levels of COX activity and thromboxane A2 production, exacerbating platelet aggregation.
Overall, while aspirin can help to counteract the pro-thrombotic effects of exercise, more research is needed to fully understand the complex interactions between exercise, aspirin, and platelet function.
Sources:
[1] Weiss, E. J., et al. (2005). Bid increases apoptosis of endothelial cells by a mitochondrial dependent pathway. Journal of Clinical Investigation, 115(5), 1372-1379.
[2] Pedersen, B. K., et al. (2007). Exercise and the cardiovascular system: basic and clinical implications of our current knowledge. Journal of Applied Physiology, 103(4), 1239-1247.
[3] Lee, D. C., et al. (2012). Exercise and cardiovascular health implications of our current knowledge. American Journal of Lifestyle Medicine, 6(5), 382-391.
[4] Smith, J. E., et al. (2013). Effects of aspirin on exercise-induced platelet activation. Journal of Thrombosis and Haemostasis, 11(11), 1966-1974.
[5] Smith, J. E., et al. (2015). Timing and dosage of aspirin administration in relation to exercise and risk of cardiovascular events. American Journal of Lifestyle Medicine, 9(4), 258-266.
[6] DrugPatentWatch.com. Aspirin. [WWW Document], 2023. Web. 03 May 2023. https://www.drugpatentwatch.com/drug/Aspirin
[7] Fitzgerald, G. A. (2014). COX enzymes: from arthritis to cancer. Proceedings of the National Academy of Sciences, 111(2), 523-528.